Flavio Ballante, Ph.D.
Affiliations: | 2010-2014 | Chemistry and Technology of Drugs | University of Rome La Sapienza, Roma, Lazio, Italy |
2014-2017 | Biochemistry and Molecular Biophysics | Washington University School of Medicine in St. Louis | |
2017-2022 | Cell and Molecular Biology | Uppsala University, Uppsala, Uppsala län, Sweden | |
2022- | Medical Biochemistry and Biophysics | Karolinska Institute, Stockholm, Sweden |
Area:
Medicinal Chemistry, Computational Chemistry, Drug Discovery, Drug DesignGoogle:
"Flavio Ballante"Parents
Sign in to add mentorGarland R. Marshall | post-doc | 2014-2017 | Washington University School of Medicine in St. Louis |
Jens Carlsson | research scientist | 2017-2022 | BMC Uppsala University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Luttens A, Vo DD, Scaletti ER, et al. (2025) Virtual fragment screening for DNA repair inhibitors in vast chemical space. Nature Communications. 16: 1741 |
Petracco E, Ferré G, Kabelka I, et al. (2025) Development of an G Protein-Coupled Receptor Fragment Molecule Screening Approach with High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance. Acs Chemical Biology |
Ballante F, Turkina MV, Ntzouni M, et al. (2023) Modified N-acyl-L-homoserine lactone compounds abrogate Las-dependent quorum-sensing response in human pathogen Pseudomonas aeruginosa Frontiers in Molecular Biosciences. 10 |
Ballante F, Kooistra AJ, Kampen S, et al. (2021) Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You? Pharmacological Reviews. 73 |
Kapla J, Rodríguez-Espigares I, Ballante F, et al. (2021) Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models? Plos Computational Biology. 17: e1008936 |
Nencetti S, Cuffaro D, Nuti E, et al. (2021) Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines. Journal of Enzyme Inhibition and Medicinal Chemistry. 36: 34-47 |
Ballante F. (2021) Protein-Ligand Interactions and Drug Design Methods in Molecular Biology. 2266: XV, 327 |
Ballante F, Rudling A, Zeifman A, et al. (2019) Docking finds GPCR ligands in dark chemical matter. Journal of Medicinal Chemistry |
Kennedy AJ, Ballante F, Johansson JR, et al. (2018) Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational Modeling. Acs Pharmacology & Translational Science. 1: 119-133 |
Ballante F. (2018) Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection Methods in Molecular Biology. 1824: 67-88 |